Engineers Gate Manager LP Chemo Centryx, Inc. Transaction History

Engineers Gate Manager LP

$4.86 Billion
Q3 2024

Shares

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$15.36 - $27.51 $196,300 - $351,577	-12,780 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$22.22 - $39.12 $11,998 - $21,124	540 Added 4.41%	12,780 $320,000
Q4 2021 Feb 14, 2022	BUY	$18.38 - $40.5 $224,971 - $495,720	12,240 New	12,240 $446,000
Q2 2021 Aug 16, 2021	SELL	$9.59 - $50.88 $49,868 - $264,576	-5,200 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$49.53 - $68.4 $52,254 - $72,162	-1,055 Reduced 16.87%	5,200 $266,000
Q4 2020 Feb 16, 2021	BUY	$47.25 - $65.16 $295,548 - $407,575	6,255 New	6,255 $387,000
Q2 2020 Aug 17, 2020	SELL	$38.58 - $65.07 $854,508 - $1.44 Million	-22,149 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$32.73 - $50.78 $724,936 - $1.12 Million	22,149 New	22,149 $890,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.